18 Apr 2017

Public offering of ordinary shares by Wave Life Sciences Ltd.

Partner Evelyn Wee and Senior Associate Cynthia Wu acted as Singapore counsel to Jefferies, Leerink Partners and Mizuho Securities USA as representatives of several underwriters under the underwriting agreement entered into with Wave Life Sciences on the offering of approximately 4.17 million ordinary shares in the capital of the company to the public at US$24 per ordinary share. Wave Life Sciences granted an over-allotment option for the underwriters to purchase up to an additional 625,000 ordinary shares. The transaction was valued at US$100 million.